cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.23566596
title: Supplementary Material for: Behavioural Activation versus Treatment as Usual for Depressed Older Adults in Primary Care: A Pragmatic Cluster-Randomised Controlled Trial

description: <b><i>Introduction:</i></b> Effective non-pharmacological treatment options for depression in older adults are lacking. <b><i>Objective:</i></b> The effectiveness of behavioural activation (BA) by mental health nurses (MHNs) for depressed older adults in primary care compared with treatment as usual (TAU) was evaluated. <b><i>Methods:</i></b> In this multicentre cluster-randomised controlled trial, 59 primary care centres (PCCs) were randomised to BA and TAU. Consenting older (≥65 years) adults (<i>n</i> = 161) with clinically relevant symptoms of depression (PHQ-9 ≥ 10) participated. Interventions were an 8-week individual MHN-led BA programme and unrestricted TAU in which general practitioners followed national guidelines. The primary outcome was self-reported depression (QIDS-SR16) at 9 weeks and 3, 6, 9, and 12-month follow-up. <b><i>Results:</i></b> Data of 96 participants from 21 PCCs in BA and 65 participants from 16 PCCs in TAU, recruited between July 4, 2016, and September 21, 2020, were included in the intention-to-treat analyses. At post-treatment, BA participants reported significantly lower severity of depressive symptoms than TAU participants (QIDS-SR16 difference = −2.77, 95% CI = −4.19 to −1.35), <i>p</i> &lt; 0.001; between-group effect size = 0.90; 95% CI = 0.42–1.38). This difference persisted up to the 3-month follow-up (QIDS-SR16 difference = −1.53, 95% CI = −2.81 to −0.26, <i>p</i> = 0.02; between-group effect size = 0.50; 95% CI = 0.07–0.92) but not up to the 12-month follow-up [QIDS-SR16 difference = −0.89 (−2.49 to 0.71)], <i>p</i> = 0.28; between-group effect size = 0.29 (95% CI = −0.82 to 0.24). <b><i>Conclusions:</i></b> BA led to a greater symptom reduction of depressive symptoms in older adults, compared to TAU in primary care, at post-treatment and 3-month follow-up, but not at 6- to 12-month follow-up.
DOI: 10.6084/m9.figshare.23566596.v1
title: Supplementary Material for: Behavioural Activation versus Treatment as Usual for Depressed Older Adults in Primary Care: A Pragmatic Cluster-Randomised Controlled Trial

description: <b><i>Introduction:</i></b> Effective non-pharmacological treatment options for depression in older adults are lacking. <b><i>Objective:</i></b> The effectiveness of behavioural activation (BA) by mental health nurses (MHNs) for depressed older adults in primary care compared with treatment as usual (TAU) was evaluated. <b><i>Methods:</i></b> In this multicentre cluster-randomised controlled trial, 59 primary care centres (PCCs) were randomised to BA and TAU. Consenting older (≥65 years) adults (<i>n</i> = 161) with clinically relevant symptoms of depression (PHQ-9 ≥ 10) participated. Interventions were an 8-week individual MHN-led BA programme and unrestricted TAU in which general practitioners followed national guidelines. The primary outcome was self-reported depression (QIDS-SR16) at 9 weeks and 3, 6, 9, and 12-month follow-up. <b><i>Results:</i></b> Data of 96 participants from 21 PCCs in BA and 65 participants from 16 PCCs in TAU, recruited between July 4, 2016, and September 21, 2020, were included in the intention-to-treat analyses. At post-treatment, BA participants reported significantly lower severity of depressive symptoms than TAU participants (QIDS-SR16 difference = −2.77, 95% CI = −4.19 to −1.35), <i>p</i> &lt; 0.001; between-group effect size = 0.90; 95% CI = 0.42–1.38). This difference persisted up to the 3-month follow-up (QIDS-SR16 difference = −1.53, 95% CI = −2.81 to −0.26, <i>p</i> = 0.02; between-group effect size = 0.50; 95% CI = 0.07–0.92) but not up to the 12-month follow-up [QIDS-SR16 difference = −0.89 (−2.49 to 0.71)], <i>p</i> = 0.28; between-group effect size = 0.29 (95% CI = −0.82 to 0.24). <b><i>Conclusions:</i></b> BA led to a greater symptom reduction of depressive symptoms in older adults, compared to TAU in primary care, at post-treatment and 3-month follow-up, but not at 6- to 12-month follow-up.
DOI: 10.5519/qd.0pigtj4f
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (9 records)
DOI: 10.6084/m9.figshare.22657444.v1
title: Supplementary Material for: Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey

description: Background: Patients’ understanding of the systemic nature of psoriatic disease (PsD) remains insufficiently explored. Objectives: To assess patients’ understanding of PsD, associated comorbidities, disease burden, and relationships with healthcare professionals (HCPs). Methods: Psoriasis and Beyond was a cross-sectional, quantitative online survey conducted in patients with a self-reported, physician-given diagnosis of moderate to severe psoriasis (body surface area [BSA] &gt;5% to &lt;10%, affecting sensitive and/or prominent body parts or BSA ≥10%) at its worst, with/without psoriatic arthritis (PsA). Patients were recruited through online panels by the Institut de Publique Sondage d'Opinion Secteur (Ipsos SA) and patient advocacy groups. Results: Overall, 4978 respondents with psoriasis completed the online survey from 20 countries across Australia, Asia, Europe, and the Americas; 30% of patients also reported having concomitant PsA. Overall, 69% of patients with psoriasis had heard that their disease was part of a systemic disease, and 60% had heard of the term “psoriatic disease”. Despite this, recognition of common manifestations and comorbidities associated with PsD was low. Among psoriasis-only patients (n=3490), 38% screened positive using the Psoriasis Epidemiology Screening Tool (PEST), indicative of potential PsA. Overall, 48% of patients reported that their disease had a very large to extremely large effect on quality of life (QoL; Dermatology Life Quality Index [DLQI] score, 11–30); only 13% of patients reported no impact of the disease on QoL (DLQI, 0–1). Most patients had experienced stigma and discrimination (82%) and a negative impact on relationships (81%) in their lives. Overall, 59% of patients were not involved in deciding their treatment goals; 58% of all treated patients (n=4757) and 64% of treated patients with concomitant PsA (n=1409) were satisfied with their current treatment. Conclusions: These results highlight that patients may not fully understand the systemic nature of their disease, were frequently uninvolved in deciding treatment goals, and were often not satisfied with their current treatment. Increasing patients’ participation in their care can facilitate shared decision-making between patients and HCPs, which may result in better treatment adherence and patient outcomes. Furthermore, these data indicate that policies should be implemented to protect against stigma and discrimination, which are commonly experienced by patients with psoriasis.
DOI: 10.5281/zenodo.8095075
title: Hecht Museum Case Study Dataset

description: Hecht Museum Case Study Dataset
DOI: 10.5281/zenodo.8095074
title: Hecht Museum Case Study Dataset

description: Hecht Museum Case Study Dataset
DOI: 10.5281/zenodo.8094928
title: ChemSec's PFAS Guide dataset

description: ChemSec's PFAS Guide: PFAS chemicals are used in many product categories, even where you least expect it. The PFAS Guide can alert you to products likely to contain these chemicals and give your company advice on how to phase them out. More information and a user interface for this dataset is available at https://pfas.chemsec.org/
DOI: 10.5281/zenodo.8094929
title: ChemSec's PFAS Guide dataset

description: ChemSec's PFAS Guide: PFAS chemicals are used in many product categories, even where you least expect it. The PFAS Guide can alert you to products likely to contain these chemicals and give your company advice on how to phase them out. More information and a user interface for this dataset is available at https://pfas.chemsec.org/
DOI: 10.5519/qd.39g9n060
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (6 records)
DOI: 10.6084/m9.figshare.23599815
title: Maternal marital satisfaction and children's anxiety the mediating role of parenting style.sav

description: In order to explore the relationship between mother's marital satisfaction and children's anxiety and to test the role of mother's parenting style, the marital satisfaction subscale developed by Spence (2001), the parenting style questionnaire the author of this study designed and the children 's anxiety scale by Yang (1998) were employed and a total of 643 children and their mothers were surveyed.
DOI: 10.48328/tudatalib-1123
title: Voltage induced damage progression on the raceway surfaces of thrust ball bearings, Part II: High Speed Measurements

description: This set of data is obtained by André Harder during his experiments on the progression of voltage induced bearing damages. The experiments were made on the bearing test rig at the Institute of Product Development and Machine Elements of the Technical University of Darmstadt in the time between December 2021 and March 2022. Thrust ball bearings were tested to investigate the damage progression on the bearing surface without destroying the bearing. The description of the test parameters, the test procedure and the explanation of the naming convention of the data can be found in the first part of the published data (see related sources). This set of data gives three additional domains of the measured data. The high speed radial and axial acceleration measurements obtained every minute of the test run are part of the A-domain. The high speed measurements of the electric voltage applied on the bearing and the corresponding electric current are part of the E-domain. Lastly, a measurement of the electric impedance of the bearing was obtained, before applying the damaging electrical signal. These measurements are part of the I-domain.
DOI: 10.5281/zenodo.8095093
title: Performance Model, Deliverable D2.4 Final Release and Evaluation of the AI-SPRINT Design Tools.

description: This repository includes the code and results of analysis for predicting unseen layers of the same network and predicting new unseen networks reported in Deliverable D2.4 Final Release and Evaluation of the AI-SPRINT Design Tools<strong>. </strong>The folder is organised as follows: - **pareto** contains the results of the profiling of the networks trained and validated on CIFAR-10 - **pareto_onnx** contains the results of the profiling of the networks trained and validated on MNIST - The folders "**network_to_network**" contain the models trained using aMLLibrary for the analysis on unseen networks done using Eduard's data. - **notebook-B5.ipynb** contains the code to perform the analysis on B and C networks - **nextLayerPrediction.ipynb** contains the code to perform the prediction of unseen layers of the same network - **allLayerPrediction.ipynb** contains the code for the analysis on unseen networks
DOI: 10.5281/zenodo.8095092
title: Performance Model, Deliverable D2.4 Final Release and Evaluation of the AI-SPRINT Design Tools.

description: This repository includes the code and results of analysis for predicting unseen layers of the same network and predicting new unseen networks reported in Deliverable D2.4 Final Release and Evaluation of the AI-SPRINT Design Tools<strong>. </strong>The folder is organised as follows: - **pareto** contains the results of the profiling of the networks trained and validated on CIFAR-10 - **pareto_onnx** contains the results of the profiling of the networks trained and validated on MNIST - The folders "**network_to_network**" contain the models trained using aMLLibrary for the analysis on unseen networks done using Eduard's data. - **notebook-B5.ipynb** contains the code to perform the analysis on B and C networks - **nextLayerPrediction.ipynb** contains the code to perform the prediction of unseen layers of the same network - **allLayerPrediction.ipynb** contains the code for the analysis on unseen networks
DOI: 10.34740/kaggle/dsv/6052262
title: Global Genomic Neurofibromatosis Neoplasia
DOI: 10.34740/kaggle/dsv/6052340
title: UK Van Brands Dataset
DOI: 10.6084/m9.figshare.23587575
title: A RabGAP-Rab GTPase pair regulates plant autophagy and immunity - Alphafold2-multimer data

description: This data set was used in the publication "A RabGAP-Rab GTPase pair regulates plant autophagy and immunity". These are AF2-multimer prediction folders that were generated by AF2.
DOI: 10.6084/m9.figshare.23587575.v1
title: A RabGAP-Rab GTPase pair regulates plant autophagy and immunity - Alphafold2-multimer data

description: This data set was used in the publication "A RabGAP-Rab GTPase pair regulates plant autophagy and immunity". These are AF2-multimer prediction folders that were generated by AF2.
DOI: 10.18465/cf839d8b-ac12-45ec-b53d-9aec179059bf
title: Trait de côte de 1999 en Pays de la Loire (côtes sableuses)

description: Polyligne numérisée à partir d'images aériennes fixant la position du trait de côte le long des côtes sableuses de la région Pays de la Loire
DOI: 10.6084/m9.figshare.23260816
title: Adaptive Testing for Alphas in High-Dimensional Factor Pricing Models

description: This article proposes a new procedure to validate the multi-factor pricing theory by testing the presence of alpha in linear factor pricing models with a large number of assets. Because the market’s inefficient pricing is likely to occur to a small fraction of exceptional assets, we develop a testing procedure that is particularly powerful against sparse signals. Based on the high-dimensional Gaussian approximation theory, we propose a simulation-based approach to approximate the limiting null distribution of the test. Our numerical studies show that the new procedure can deliver a reasonable size and achieve substantial power improvement compared to the existing tests under sparse alternatives, and especially for weak signals.
DOI: 10.6084/m9.figshare.23260816.v2
title: Adaptive Testing for Alphas in High-Dimensional Factor Pricing Models

description: This article proposes a new procedure to validate the multi-factor pricing theory by testing the presence of alpha in linear factor pricing models with a large number of assets. Because the market’s inefficient pricing is likely to occur to a small fraction of exceptional assets, we develop a testing procedure that is particularly powerful against sparse signals. Based on the high-dimensional Gaussian approximation theory, we propose a simulation-based approach to approximate the limiting null distribution of the test. Our numerical studies show that the new procedure can deliver a reasonable size and achieve substantial power improvement compared to the existing tests under sparse alternatives, and especially for weak signals.
DOI: 10.6084/m9.figshare.23599992
title: Interview Transcript.docx

description: Interview transcript in word document, with facilitator and 2 interviewees/participants. Used as part of data collection for pilot study in medical education research in simulation project.
DOI: 10.6084/m9.figshare.23599998
title: original Data.xlsx

description: This file is the original dataset of paper "Seasonal characteristics of biogenic dimethylated sulfur compounds and their response to ocean acidification and Fe addition in the Changjiang Estuary"
DOI: 10.6084/m9.figshare.23599998.v1
title: original Data.xlsx

description: This file is the original dataset of paper "Seasonal characteristics of biogenic dimethylated sulfur compounds and their response to ocean acidification and Fe addition in the Changjiang Estuary"
DOI: 10.6084/m9.figshare.23599461.v1
title: Metagenome-assembled genomes (MAGs)

description: We assembled a total of 4444 medium- to high-quality metagenome-assembled genomes (MAGs) with completeness &gt; 50% and contamination &lt; 5%, from floc-associated bacterial community of a commercial shrimp biofloc aquaculture system, located in South Korea.
DOI: 10.6084/m9.figshare.23599995
title: Anonymised survey results.docx

description: Anonymised student survey results (in word document).
DOI: 10.6084/m9.figshare.23599995.v1
title: Anonymised survey results.docx

description: Anonymised student survey results (in word document).
DOI: 10.34740/kaggle/dsv/6052445
title: YouTube Trending Video Dataset (updated daily)
DOI: 10.34740/kaggle/dsv/6052443
title: 2021 World Population (updated daily)
DOI: 10.5281/zenodo.7428617
title: Images for pdb entry 8BXR Titin FnIII-domain I109-I111 (I/A4-A/A6) from the MIR region

description: Structure for 8BXR Titin FnIII-domain I109-I111 (I/A4-A/A6) from the MIR region calculated from these two merged data sets.
DOI: 10.5281/zenodo.7428616
title: Images for pdb entry 8BXR Titin FnIII-domain I109-I111 (I/A4-A/A6) from the MIR region

description: Structure for 8BXR Titin FnIII-domain I109-I111 (I/A4-A/A6) from the MIR region calculated from these two merged data sets.
DOI: 10.34740/kaggle/dsv/6052439
title: Economy of the United States by Presidents
DOI: 10.57745/bwpqzf
title: Supplementary table 2 28 06 2023.tab

description: Dorbani et al 2023 Supplementary data
DOI: 10.57745/f1fj3p
title: Supplementary table 1-2 13 12 2022.tab

description: Supplementary Data to Dorbani et al. (2022) submitted to IFSET
DOI: 10.57745/ghvhcz
title: Supplementary table 1 28 06 2023.tab

description: Dorbani et al. 2023 Supplementary data
DOI: 10.25345/c5959cj3m
title: MassIVE MSV000092307 - GNPS_Metabolomics_SummerSchool_2023
title: Subset of MassIVE MSV000085944 data published by Panitchpakdi and collaborators (2022) used during Metabolomics Summer School 2023 at Statens Serum Institut, Copenhagen. Panitchpakdi M, Weldon KC, Jarmusch AK, Gentry EC, Choi A, Sepulveda Y, et al. (2022) Non-invasive skin sampling detects systemically administered drugs in humans. PLoS ONE 17(7): e0271794. https://doi.org/10.1371/journal.pone.0271794
DOI: 10.48579/pro/dockdi/bg5xmp
title: fiche-role-agri6-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/vcmq9l
title: fiche-role-agri1-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/cpcbkg
title: fiche-role-agri5-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/g0idce
title: fiche-role-agri9-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/jaiwxq
title: fiche-role-agri7-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/nikk2t
title: fiche-role-elu3-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/ou6pq0
title: plateau-central.jpg

description: :unav
DOI: 10.48579/pro/dockdi/vkoelr
title: cartes-action-page-007.jpg

description: :unav
DOI: 10.48579/pro/dockdi/02ezaa
title: fiche-role-agri7-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/6kaqav
title: fiche-role-agri2-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/ajkhmp
title: cartes-action-page-003.jpg

description: :unav
DOI: 10.48579/pro/dockdi/clf7z0
title: cartes-action-page-001.jpg

description: :unav
DOI: 10.48579/pro/dockdi/mc6prx
title: fiche-role-elu1-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/qeiiiq
title: fiche-role-agri2-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/fmwr8r
title: fiche-role-elu1-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/gh8xys
title: cartes-action-page-009.jpg

description: :unav
DOI: 10.48579/pro/dockdi/qnj9xv
title: cartes-competence-agri-page-006.jpg

description: :unav
DOI: 10.48579/pro/dockdi/qzhcvh
title: fiche-role-agri4-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/s97wsc
title: fiche-role-agri1-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/zre5xs
title: cartes-competence-agri-page-005.jpg

description: :unav
DOI: 10.48579/pro/dockdi/dkqnun
title: fiche-role-agri6-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/etcgah
title: fiche-role-elu2-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/pnnhhb
title: cartes-action-page-004.jpg

description: :unav
DOI: 10.48579/pro/dockdi/pse4zf
title: fiche-role-agri8-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/qoo159
title: cartes-action-page-008.jpg

description: :unav
DOI: 10.48579/pro/dockdi/trpyat
title: fiche-role-gestionnaire-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/0ryirq
title: fiche-role-elu2-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/ale6sw
title: cartes-competence-agri-page-002.jpg

description: :unav
DOI: 10.48579/pro/dockdi/jl5ccs
title: fiche-role-elu3-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/lmcoh0
title: fiche-role-gestionnaire-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/ow79db
title: fiche-role-agri4-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/tolwmi
title: cartes-competence-agri-page-001.jpg

description: :unav
DOI: 10.48579/pro/dockdi/hhsbza
title: plateau-amont.jpg

description: :unav
DOI: 10.48579/pro/dockdi/jvxlrt
title: fiche-role-agri8-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/lezosb
title: fiche-role-agri3-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/vvwau0
title: fiche-role-agri9-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/wdbkub
title: fiche-role-agri3-recto.jpg

description: :unav
DOI: 10.48579/pro/dockdi/c03ql7
title: cartes-action-page-002.jpg

description: :unav
DOI: 10.48579/pro/dockdi/f28mtl
title: cartes-competence-agri-page-009.jpg

description: :unav
DOI: 10.48579/pro/dockdi/fber0u
title: plateau-aval.jpg

description: :unav
DOI: 10.48579/pro/dockdi/fphfwv
title: cartes-competence-agri-page-008.jpg

description: :unav
DOI: 10.48579/pro/dockdi/gijotv
title: cartes-action-page-005.jpg

description: :unav
DOI: 10.48579/pro/dockdi/lke9ej
title: cartes-competence-agri-page-004.jpg

description: :unav
DOI: 10.48579/pro/dockdi/4zuxat
title: cartes-action-page-006.jpg

description: :unav
DOI: 10.48579/pro/dockdi/bbmgxv
title: fiche-role-agri5-verso.jpg

description: :unav
DOI: 10.48579/pro/dockdi/d4mnrw
title: cartes-competence-agri-page-007.jpg

description: :unav
DOI: 10.48579/pro/dockdi/i8naln
title: thumbnail.png

description: :unav
DOI: 10.48579/pro/dockdi/uskhck
title: cartes-competence-agri-page-003.jpg

description: :unav
DOI: 10.6084/m9.figshare.23600037
title: Humoral and cellular response to vaccination agains SARS COV-2

description: Dataset for the study on "<strong>Response to immunization against SARS-CoV-2 and risk of Omicron infection in dialysis patients: a prospective cohort study"</strong>
DOI: 10.6084/m9.figshare.23600037.v1
title: Humoral and cellular response to vaccination agains SARS COV-2

description: Dataset for the study on "<strong>Response to immunization against SARS-CoV-2 and risk of Omicron infection in dialysis patients: a prospective cohort study"</strong>
DOI: 10.5281/zenodo.8095478
title: aegina_citrea_spades_01.fasta.gz

description: .
DOI: 10.5281/zenodo.8095477
title: aegina_citrea_spades_01.fasta.gz

description: .
DOI: 10.5281/zenodo.8052875
title: Accounting for behaviour in fine-scale habitat selection: a case study highlighting methodological intricacies

description: Data for the article “Accounting for behaviour in fine-scale habitat selection: a case study highlighting methodological intricacies” By LT Beumer, NMS Schmidt, J Pohle, J Signer, M Chimienti, JP Desforges, LH Hansen, SH Pedersen, DA Rudd, M Stelvig, FM van Beest The data set includes five files: A readme file describing the data files, and four data files accompanying the above publication. For further queries please contact Larissa T. Beumer: ltbeumer@gmail.com